Skip to main content
Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.383
+0.015 (4.19%)
At close: May 17, 2024, 4:00 PM
0.388
+0.005 (1.20%)
After-hours: May 17, 2024, 7:58 PM EDT

Lyra Therapeutics Revenue

Lyra Therapeutics had revenue of $1.68M in the twelve months ending March 31, 2024, with 28.74% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $532.00K with 29.76% year-over-year growth. In the year 2023, Lyra Therapeutics had annual revenue of $1.56M with 14.31% growth.

Revenue (ttm)
$1.68M
Revenue Growth
+28.74%
P/S Ratio
13.96
Revenue / Employee
$15,413
Employees
109
Market Cap
23.46M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.56M195.00K14.31%
Dec 31, 20221.36M1.08M378.25%
Dec 31, 2021285.00K--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20181.24M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LYRA News

More News